Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07596940 · ClinicalTrials.gov registry record · NA
A Health Game Intervention for Cancer and Post-ICU Patients Suffering From Acute Cognitive Impairment
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT07596940: Completed NA study, sponsored by University of Cincinnati.
NCT07596940 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07596940, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Millions of patients each year suffer from acute cognitive impairment caused by traumatic brain injury, stroke, Parkinson's disease, etc. Despite increasing incidences and morbidity, effective pharmacological interventions continue to show a lack of improvement for brain cancer patients. Studies thus far have shown that non-pharmacological interventions have contributed to early success in addressing some forms of cognitive impairment for patients with cognitive dysfunction. We have built a phase-one fully functioning game Hometown Bound that offers cognitive challenges to patients. The aim of this study is to observe for measured improvement of cognitive function among brain cancer patients, which will be validated by the four cognitive scales, measuring efficacy. The first three scales measure patient baseline impairment before and after game play.
Primary Outcome
The test consists of a 12-item word list, composed of four words from each of the three semantic categories. The participant listens and memorizes the words as the examiner reads the complete word list of 12 items. This is followed by the participant's attempt to recite back the list of words in any order.
Interventions
- DEVICE VR cognitive training platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-07-03 |
| Est. Completion | 2024-06-10 |
| Phase | NA |
What the finished NCT07596940 record still lists
NCT07596940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which VR cognitive training platform is the first listed.
NCT07596940 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07596940 about?
NCT07596940 is a clinical study titled "A Health Game Intervention for Cancer and Post-ICU Patients Suffering From Acute Cognitive Impairment". Millions of patients each year suffer from acute cognitive impairment caused by traumatic brain injury, stroke, Parkinson's disease, etc. Despite increasing incidences and morbidity, effective pharmacological interventions continue to show a lack of improvement for brain cancer patients. Studies thu...
What is the current status of trial NCT07596940?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-07-03. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT07596940?
The interventions under investigation include: VR cognitive training platform (DEVICE).
Who is sponsoring clinical trial NCT07596940?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07596940's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI